Transaction · 0001225208-26-007620

O'Connor Padraig Andrew

O'Connor Padraig Andrew, EVP, GO, reported a transaction classified as withholding at BOSTON SCIENTIFIC CORP involving 567.000000 shares for an estimated $27425.79. Reported holdings after the transaction were 7892.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GO
BSXBOSTON SCIENTIFIC CORP
Filing timeSep 03
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$46.95
Pre-filing
1mo ago +3.2%1w ago +2.6%1d ago +2.4%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

BSX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BSX since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001225208-26-007620
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 03, 2026, 08:34 PM · 1d delay
Shares
567 sh
$4.83k per share
Estimated value
-$2.74M
Computed from shares × price
Holdings after
7.89k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Global Operations

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

  2. F2

    Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

  3. F3

    Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.

Original filing · 0001225208-26-007620
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BSX